Copyright Reports & Markets. All rights reserved.

Global DTaP and Tdap Vaccines Sales Market Report 2021

Request for Sample of this report
Buy now

1 DTaP and Tdap Vaccines Market Overview

  • 1.1 DTaP and Tdap Vaccines Product Scope
  • 1.2 DTaP and Tdap Vaccines Segment by Type
    • 1.2.1 Global DTaP and Tdap Vaccines Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 DTaP
    • 1.2.3 Td
    • 1.2.4 Tdap
  • 1.3 DTaP and Tdap Vaccines Segment by Application
    • 1.3.1 Global DTaP and Tdap Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Adult
    • 1.3.3 Pediatric
  • 1.4 DTaP and Tdap Vaccines Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global DTaP and Tdap Vaccines Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global DTaP and Tdap Vaccines Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global DTaP and Tdap Vaccines Price Trends (2016-2027)

2 DTaP and Tdap Vaccines Estimates and Forecasts by Region

  • 2.1 Global DTaP and Tdap Vaccines Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global DTaP and Tdap Vaccines Sales Market Share by Region (2016-2021)
    • 2.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Region (2016-2021)
  • 2.3 Global DTaP and Tdap Vaccines Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global DTaP and Tdap Vaccines Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global DTaP and Tdap Vaccines Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
    • 2.4.2 Europe DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
    • 2.4.3 China DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
    • 2.4.4 Japan DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
    • 2.4.6 India DTaP and Tdap Vaccines Estimates and Projections (2016-2027)

3 Global DTaP and Tdap Vaccines Competition Landscape by Players

  • 3.1 Global Top DTaP and Tdap Vaccines Players by Sales (2016-2021)
  • 3.2 Global Top DTaP and Tdap Vaccines Players by Revenue (2016-2021)
  • 3.3 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DTaP and Tdap Vaccines as of 2020)
  • 3.4 Global DTaP and Tdap Vaccines Average Price by Company (2016-2021)
  • 3.5 Manufacturers DTaP and Tdap Vaccines Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global DTaP and Tdap Vaccines Market Size by Type

  • 4.1 Global DTaP and Tdap Vaccines Historic Market Review by Type (2016-2021)
    • 4.1.1 Global DTaP and Tdap Vaccines Sales Market Share by Type (2016-2021)
    • 4.1.2 Global DTaP and Tdap Vaccines Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global DTaP and Tdap Vaccines Price by Type (2016-2021)
  • 4.2 Global DTaP and Tdap Vaccines Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2022-2027)
    • 4.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global DTaP and Tdap Vaccines Price Forecast by Type (2022-2027)

5 Global DTaP and Tdap Vaccines Market Size by Application

  • 5.1 Global DTaP and Tdap Vaccines Historic Market Review by Application (2016-2021)
    • 5.1.1 Global DTaP and Tdap Vaccines Sales Market Share by Application (2016-2021)
    • 5.1.2 Global DTaP and Tdap Vaccines Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global DTaP and Tdap Vaccines Price by Application (2016-2021)
  • 5.2 Global DTaP and Tdap Vaccines Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2022-2027)
    • 5.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global DTaP and Tdap Vaccines Price Forecast by Application (2022-2027)

6 North America DTaP and Tdap Vaccines Market Facts & Figures

  • 6.1 North America DTaP and Tdap Vaccines Sales by Company
    • 6.1.1 North America DTaP and Tdap Vaccines Sales by Company (2016-2021)
    • 6.1.2 North America DTaP and Tdap Vaccines Revenue by Company (2016-2021)
  • 6.2 North America DTaP and Tdap Vaccines Sales Breakdown by Type
    • 6.2.1 North America DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
  • 6.3 North America DTaP and Tdap Vaccines Sales Breakdown by Application
    • 6.3.1 North America DTaP and Tdap Vaccines Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America DTaP and Tdap Vaccines Sales Breakdown by Application (2022-2027)

7 Europe DTaP and Tdap Vaccines Market Facts & Figures

  • 7.1 Europe DTaP and Tdap Vaccines Sales by Company
    • 7.1.1 Europe DTaP and Tdap Vaccines Sales by Company (2016-2021)
    • 7.1.2 Europe DTaP and Tdap Vaccines Revenue by Company (2016-2021)
  • 7.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Type
    • 7.2.1 Europe DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
  • 7.3 Europe DTaP and Tdap Vaccines Sales Breakdown by Application
    • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China DTaP and Tdap Vaccines Market Facts & Figures

  • 8.1 China DTaP and Tdap Vaccines Sales by Company
    • 8.1.1 China DTaP and Tdap Vaccines Sales by Company (2016-2021)
    • 8.1.2 China DTaP and Tdap Vaccines Revenue by Company (2016-2021)
  • 8.2 China DTaP and Tdap Vaccines Sales Breakdown by Type
    • 8.2.1 China DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
    • 8.2.2 China DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
  • 8.3 China DTaP and Tdap Vaccines Sales Breakdown by Application
    • 8.3.1 China 158 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 158 Sales Breakdown by Application (2022-2027)

9 Japan DTaP and Tdap Vaccines Market Facts & Figures

  • 9.1 Japan DTaP and Tdap Vaccines Sales by Company
    • 9.1.1 Japan DTaP and Tdap Vaccines Sales by Company (2016-2021)
    • 9.1.2 Japan DTaP and Tdap Vaccines Revenue by Company (2016-2021)
  • 9.2 Japan DTaP and Tdap Vaccines Sales Breakdown by Type
    • 9.2.1 Japan DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
  • 9.3 Japan DTaP and Tdap Vaccines Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia DTaP and Tdap Vaccines Market Facts & Figures

  • 10.1 Southeast Asia DTaP and Tdap Vaccines Sales by Company
    • 10.1.1 Southeast Asia DTaP and Tdap Vaccines Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia DTaP and Tdap Vaccines Revenue by Company (2016-2021)
  • 10.2 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Type
    • 10.2.1 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India DTaP and Tdap Vaccines Market Facts & Figures

  • 11.1 India DTaP and Tdap Vaccines Sales by Company
    • 11.1.1 India DTaP and Tdap Vaccines Sales by Company (2016-2021)
    • 11.1.2 India DTaP and Tdap Vaccines Revenue by Company (2016-2021)
  • 11.2 India DTaP and Tdap Vaccines Sales Breakdown by Type
    • 11.2.1 India DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
    • 11.2.2 India DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
  • 11.3 India DTaP and Tdap Vaccines Sales Breakdown by Application
    • 11.3.1 India DTaP and Tdap Vaccines Sales Breakdown by Application (2016-2021)
    • 11.3.2 India DTaP and Tdap Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in DTaP and Tdap Vaccines Business

  • 12.1 Sanofi Pasteur
    • 12.1.1 Sanofi Pasteur Corporation Information
    • 12.1.2 Sanofi Pasteur Business Overview
    • 12.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
    • 12.1.5 Sanofi Pasteur Recent Development
  • 12.2 GlaxoSmithKline
    • 12.2.1 GlaxoSmithKline Corporation Information
    • 12.2.2 GlaxoSmithKline Business Overview
    • 12.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
    • 12.2.5 GlaxoSmithKline Recent Development
  • 12.3 Protein Sciences Corporation
    • 12.3.1 Protein Sciences Corporation Corporation Information
    • 12.3.2 Protein Sciences Corporation Business Overview
    • 12.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
    • 12.3.5 Protein Sciences Corporation Recent Development
  • 12.4 Novartis AG
    • 12.4.1 Novartis AG Corporation Information
    • 12.4.2 Novartis AG Business Overview
    • 12.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
    • 12.4.5 Novartis AG Recent Development
  • 12.5 Seqirus
    • 12.5.1 Seqirus Corporation Information
    • 12.5.2 Seqirus Business Overview
    • 12.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
    • 12.5.5 Seqirus Recent Development
  • 12.6 Merck Sharp & Dohme Corp
    • 12.6.1 Merck Sharp & Dohme Corp Corporation Information
    • 12.6.2 Merck Sharp & Dohme Corp Business Overview
    • 12.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
    • 12.6.5 Merck Sharp & Dohme Corp Recent Development
  • 12.7 Astellas Pharma US, Inc
    • 12.7.1 Astellas Pharma US, Inc Corporation Information
    • 12.7.2 Astellas Pharma US, Inc Business Overview
    • 12.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
    • 12.7.5 Astellas Pharma US, Inc Recent Development
  • 12.8 Pfizer Inc
    • 12.8.1 Pfizer Inc Corporation Information
    • 12.8.2 Pfizer Inc Business Overview
    • 12.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
    • 12.8.5 Pfizer Inc Recent Development
  • 12.9 Johnson & Johnson
    • 12.9.1 Johnson & Johnson Corporation Information
    • 12.9.2 Johnson & Johnson Business Overview
    • 12.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
    • 12.9.5 Johnson & Johnson Recent Development
  • 12.10 Lanzhou Institute of Biological Products Co., Ltd
    • 12.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
    • 12.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
    • 12.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
    • 12.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
  • 12.11 AstraZeneca
    • 12.11.1 AstraZeneca Corporation Information
    • 12.11.2 AstraZeneca Business Overview
    • 12.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 AstraZeneca DTaP and Tdap Vaccines Products Offered
    • 12.11.5 AstraZeneca Recent Development
  • 12.12 Emergent BioSolutions Inc
    • 12.12.1 Emergent BioSolutions Inc Corporation Information
    • 12.12.2 Emergent BioSolutions Inc Business Overview
    • 12.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Products Offered
    • 12.12.5 Emergent BioSolutions Inc Recent Development

13 DTaP and Tdap Vaccines Manufacturing Cost Analysis

  • 13.1 DTaP and Tdap Vaccines Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines
  • 13.4 DTaP and Tdap Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 DTaP and Tdap Vaccines Distributors List
  • 14.3 DTaP and Tdap Vaccines Customers

15 Market Dynamics

  • 15.1 DTaP and Tdap Vaccines Market Trends
  • 15.2 DTaP and Tdap Vaccines Drivers
  • 15.3 DTaP and Tdap Vaccines Market Challenges
  • 15.4 DTaP and Tdap Vaccines Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global DTaP and Tdap Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DTaP and Tdap Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    DTaP
    Td
    Tdap

    Segment by Application
    Adult
    Pediatric

    The DTaP and Tdap Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the DTaP and Tdap Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Sanofi Pasteur
    GlaxoSmithKline
    Protein Sciences Corporation
    Novartis AG
    Seqirus
    Merck Sharp & Dohme Corp
    Astellas Pharma US, Inc
    Pfizer Inc
    Johnson & Johnson
    Lanzhou Institute of Biological Products Co., Ltd
    AstraZeneca
    Emergent BioSolutions Inc

    Buy now